TR201914037A2 - Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi - Google Patents

Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi

Info

Publication number
TR201914037A2
TR201914037A2 TR2019/14037A TR201914037A TR201914037A2 TR 201914037 A2 TR201914037 A2 TR 201914037A2 TR 2019/14037 A TR2019/14037 A TR 2019/14037A TR 201914037 A TR201914037 A TR 201914037A TR 201914037 A2 TR201914037 A2 TR 201914037A2
Authority
TR
Turkey
Prior art keywords
multiple sclerosis
alantolacton
drug candidate
sclerosis disease
disease
Prior art date
Application number
TR2019/14037A
Other languages
English (en)
Inventor
Eken Ahmet
Altuntaş Hami̇yet
Çakir Mustafa
Original Assignee
T C Erciyes Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T C Erciyes Ueniversitesi filed Critical T C Erciyes Ueniversitesi
Priority to TR2019/14037A priority Critical patent/TR201914037A2/tr
Publication of TR201914037A2 publication Critical patent/TR201914037A2/tr

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Buluş, Alantolaktone (ALT) etken maddesinin Multiple Sklerozis (MS) hastalığı tedavisinde ilaç adayı veya gıda takviyesi olarak kullanımı ile ilgilidir.
TR2019/14037A 2019-09-16 2019-09-16 Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi TR201914037A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2019/14037A TR201914037A2 (tr) 2019-09-16 2019-09-16 Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/14037A TR201914037A2 (tr) 2019-09-16 2019-09-16 Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi

Publications (1)

Publication Number Publication Date
TR201914037A2 true TR201914037A2 (tr) 2021-04-21

Family

ID=76502933

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/14037A TR201914037A2 (tr) 2019-09-16 2019-09-16 Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi

Country Status (1)

Country Link
TR (1) TR201914037A2 (tr)

Similar Documents

Publication Publication Date Title
JOP20200011B1 (ar) مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp
JOP20220008A1 (ar) مثبطات parp1
EA202090019A1 (ru) Спироциклические индолины в качестве модуляторов il-17
EP3607074A4 (en) REDUCTION OR ELIMINATION OF IMMUNE RESPONSES TO NON-INTRAVENOUS THERAPEUTIC PROTEINS, FOR EXAMPLE SUBCUTANEOUSLY
JOP20170107B1 (ar) مشتقات سلفوناميد عطرية
MX393057B (es) Compuestos de indol carboxamida útiles como inhibidores de cinasas.
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
MX2020011100A (es) Compuestos, composiciones farmaceuticas y metodos de uso de agonistas de ppar.
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
CR20210686A (es) Análogos de 3–(5–metil–1,3–tiazol–2–il)–n–{(1r)–1–[2–(trifluor–metil)pirimidin–5–il]etil}benzamida
EA202190510A1 (ru) Новое лекарственное средство для лечения воспалительной болезни кишечника
MX2021000542A (es) Apirasas solubilizadas, metodos y usos.
EA201992117A1 (ru) Фармацевтическая комбинация, содержащая понесимод
EA202190398A1 (ru) Конденсированное кольцевое производное, применяемое в качестве ингибитора fgfr4
MX2022006502A (es) Composiciones farmaceuticas.
WO2020121123A3 (en) Cyclopentyl nucleoside analogs as anti-virals
MX381234B (es) Agente preventivo y/o terapéutico de enfermedad inmune.
BR112019017314A2 (pt) composições farmacêuticas para terapia de combinação
TR201914037A2 (tr) Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi
CL2020000251A1 (es) Derivado de adamantilmetilamina y uso del mismo como producto farmacéutico.
TR201914034A2 (tr) Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi
EA202090028A1 (ru) Способы уменьшения или предотвращения сердечно-сосудистых явлений у пациентов с сахарным диабетом ii типа
UA122847C2 (uk) Лікувальний комплекс для лікування діабету другого типу та діабетичної дисліпідемії
MX384394B (es) Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas.